Caused by heart and/or blood-vascular system disorders, cardiovascular (CDV) diseases kill almost 17 million people annually. The cardiovascular market can be divided the following key segments: cardiac surgery, cardiac rhythm management (abbreviated as CRM) and interventional cardiology. There is a wide range of products on offer in the market: defibrillators, introducers, catheters, pacemakers, among others.
The growth of the cardiovascular market is driven by the aging population, rising incidence of chronic CDV, innovations and technology advancements in the cardiovascular industry and constantly improving treatment capabilities. The USA is the largest cardiovascular market, with AstraZeneca , Merck & Co. , Bristol-Myers Squibb (BMS), Novartis , Sanofi-Aventis and Pfizerbeing amid the most prominent market participants.
Comprehensive assessment of the cardiovascular market at various geographical scales and over different time spans is provided in the research reports found under this catalogue. Data demand and supply trends, research and development activities, and leading market players are at hand in the reports. Moreover, future prospects for the market are disclosed in the research reports.
Publications found:
70
Sort by:
European Markets for Interventional Cardiology 2009 (15 Countries)
US$ 11,495.00
... 2008, the European market for interventional cardiology was valued at over €1.5 billion. The interventional cardiology market includes drug-eluting stents, ... devices, and IVUS catheters. In addition, this report covers the emerging markets for optical coherence tomography (OCT), vulnerable plaque screening, PFO ...
October 2009
409 pages
U.S. Market for Interventional Cardiology 2009
US$ 7,495.00
In 2008, the U.S. market for interventional cardiology was valued at $US 4.6 billion. This value represents drug-eluting stents, PTCA balloons, coronary closure devices, bare-metal stents, embolic protection devices, interventional guidewires, diagnostic catheters, ...
April 2009
312 pages
Worldwide Heart Valve Market: Focus on Tissue Valves
US$ 800.00
... worldwide annually. In the US alone, around five million people suffer from heart problems. In heart valve market, mechanical valves are more durable than tissue heart valves ... of the heart valve market. It analyzes the worldwide and US market. Apart from providing a competitive landscape of the market, the ...
May 2008
24 pages
